Results 141 to 150 of about 7,611 (182)

Safety of Tirofiban in Acute Ischemic Stroke

open access: yesStroke, 2011
Background and Purpose— Tirofiban is a highly selective, fast-acting nonpeptide glycoprotein IIb/IIIa platelet receptor antagonist with a short half-life time.
Joachim Rother, Arno Villringer
exaly   +3 more sources

Low-Dose Tirofiban Improves Functional Outcome in Acute Ischemic Stroke Patients Treated With Endovascular Thrombectomy

open access: yesStroke, 2017
Background and Purpose— Chinese patients largely experience acute ischemic stroke (AIS) because of large artery atherosclerosis rather than cardioembolism, and whether tirofiban is safe and effective in these patients treated ...
Xunming Ji, Wuwei Feng, Wenbo Zhao
exaly   +2 more sources

Intraarterial Versus Intravenous Tirofiban as an Adjunct to Endovascular Thrombectomy for Acute Ischemic Stroke

open access: yesStroke, 2020
Background and Purpose: This study aimed to evaluate the treatment effect of intraarterial versus intravenous tirofiban during endovascular thrombectomy in acute ischemic stroke.
Jianhong Yang   +2 more
exaly   +2 more sources

Cangrelor, Tirofiban, and Chewed or Standard Prasugrel Regimens in Patients With ST-Segment–Elevation Myocardial Infarction [PDF]

open access: yesCirculation, 2020
BACKGROUND Standard administration of newer oral P2Y$_{12}$ inhibitors, including prasugrel or ticagrelor, provides suboptimal early inhibition of platelet aggregation (IPA) in patients with ST-segment-elevation myocardial infarction undergoing primary ...
Pietro Minuz   +2 more
exaly   +3 more sources

Tirofiban

Drugs of Today, 1999
Tirofiban is an antagonist of the gpIIb/IIIa receptor. It was developed as an intravenous agent for rapid, potent and reversible inhibition of platelet aggregation. It produces dose-related inhibition of aggregation. Its efficacy has been demonstrated in disease states associated with intravascular thrombus formation, such as occurs with unstable ...
openaire   +2 more sources

Home - About - Disclaimer - Privacy